A Rare Case of ABO-Incompatible Living Donor Liver Transplant in Hyperacute Liver

Hepatitis A virus (HAV) infection is usually self-limiting; however, acute liver failure (ALF) is a rare, life- threatening complication that may require emergency liver transplantation. When no ABO-compatible donor is available, ABO-incompatible living donor liver transplantation (ABOi-LDLT) may be the only option. However, preformed anti-donor antibodies increase the risk of antibody-mediated rejection, and conventional desensitisation may not be feasible when transplantation cannot be delayed. We report the case of a previously healthy 26-year-old man (blood group O positive) with HAV-related ALF who presented with grade IV hepatic encephalopathy, prothrombin time (international normalised ratio [INR]) 5.64, serum glutamate pyruvate transaminase (SGPT) 4615 U/L, lactate 12 mmol/L, and pH 7.2 (King's College Criteria [KCC] positive). He required intubation, mechanical ventilation, and continuous renal replacement therapy with haemoadsorption. As no compatible donor was available, emergency ABOi-LDLT was performed within 24 hours of admission using a right-lobe graft from his B-positive mother. Preoperative plasma exchange reduced anti-B IgG and IgM titres from 1:128 and 1:64 to 1:16 and 1:4, respectively. Intraoperative splenectomy and rituximab administration in two divided doses (intraoperatively and on postoperative Day 5), along with corticosteroids, triple immunosuppression, and serial antibody titre monitoring, were employed as part of the individualised desensitisation strategy. The postoperative course was complicated by ventilator-associated pneumonia due to carbapenem-resistant Klebsiella pneumoniae and Stenotrophomonas maltophilia, which was treated according to culture sensitivity, with temporary withholding of mycophenolate mofetil. A subsequent rise in antibody titres without associated graft dysfunction was managed successfully with intravenous immunoglobulin (IVIG), highlighting the importance of antibody surveillance and tailored postoperative management. The patient was weaned from mechanical ventilation and discharged on postoperative Day 17 with stable graft function and no evidence of rejection. This case demonstrates that emergency ABOi-LDLT may be feasible in selected patients with rapidly progressive ALF when an ABO-compatible donor is unavailable, provided that individualised antibody reduction, close serological monitoring, and vigilant postoperative critical care are available.

Authors

Publication Details

Published
2026-11-16
DOI
https://doi.org/10.62830/mmj3-04-12c
Primary Topic
Organ Transplantation Techniques and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A Rare Case of ABO-Incompatible Living Donor Liver Transplant in Hyperacute Liver

Radhika Ruhatiya
1 links
Organ Transplantation Techniques and Outcomes
article

A Rare Case of ABO-Incompatible Living Donor Liver Transplant in Hyperacute Liver

Radhika Ruhatiya
article en

Abstract

Hepatitis A virus (HAV) infection is usually self-limiting; however, acute liver failure (ALF) is a rare, life- threatening complication that may require emergency liver transplantation. When no ABO-compatible donor is available, ABO-incompatible living donor liver transplantation (ABOi-LDLT) may be the only option. However, preformed anti-donor antibodies increase the risk of antibody-mediated rejection, and conventional desensitisation may not be feasible when transplantation cannot be delayed. We report the case of a previously healthy 26-year-old man (blood group O positive) with HAV-related ALF who presented with grade IV hepatic encephalopathy, prothrombin time (international normalised ratio [INR]) 5.64, serum glutamate pyruvate transaminase (SGPT) 4615 U/L, lactate 12 mmol/L, and pH 7.2 (King's College Criteria [KCC] positive). He required intubation, mechanical ventilation, and continuous renal replacement therapy with haemoadsorption. As no compatible donor was available, emergency ABOi-LDLT was performed within 24 hours of admission using a right-lobe graft from his B-positive mother. Preoperative plasma exchange reduced anti-B IgG and IgM titres from 1:128 and 1:64 to 1:16 and 1:4, respectively. Intraoperative splenectomy and rituximab administration in two divided doses (intraoperatively and on postoperative Day 5), along with corticosteroids, triple immunosuppression, and serial antibody titre monitoring, were employed as part of the individualised desensitisation strategy. The postoperative course was complicated by ventilator-associated pneumonia due to carbapenem-resistant Klebsiella pneumoniae and Stenotrophomonas maltophilia, which was treated according to culture sensitivity, with temporary withholding of mycophenolate mofetil. A subsequent rise in antibody titres without associated graft dysfunction was managed successfully with intravenous immunoglobulin (IVIG), highlighting the importance of antibody surveillance and tailored postoperative management. The patient was weaned from mechanical ventilation and discharged on postoperative Day 17 with stable graft function and no evidence of rejection. This case demonstrates that emergency ABOi-LDLT may be feasible in selected patients with rapidly progressive ALF when an ABO-compatible donor is unavailable, provided that individualised antibody reduction, close serological monitoring, and vigilant postoperative critical care are available.

Vol. III(04)
Good health and well-being
Organ Transplantation Techniques and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon